Semaglutide: The Truth Behind Wegovy, Alzheimer’s, and What No Influencer Will Tell You

If you've been keeping an eye on health trends, or simply walked past a pharmacy in the last few months, you've probably heard of semaglutide. It's that tricky name everyone associates with the famous weight-loss pen, but trust me, the story goes far beyond mirror selfies or miracle recipes we see on social media. As someone who's covered the pharmaceutical sector for years, I'm going to tell you what's really going on, especially after the data leaked at international conferences that gave the conversation an unexpected twist.

The boom of the famous "pen" and what it hides

The arrival of medications like Wegovy and Ozempic revolutionised the way we see the treatment of diabetes and obesity. On the streets of Mexico City or Monterrey, it's not unusual to hear someone asking for Wegovy 0.25mg, that specific presentation that comes in a box with a pre-filled pen containing 1.5mL of solution for subcutaneous use plus 4 Novofine Plus needles. It's the starter dose, the one many look for to begin treatment. But here's the first hard truth: this isn't a toy. When I see that semaglutide being sold as the magic solution to drop five kilos in a month without breaking a sweat, it makes my skin crawl. Because it's a potent drug, and like any potent drug, it comes with rules.

The news no one saw coming: Goodbye to hope against Alzheimer's?

A few months ago, the scientific community was buzzing with excitement. There was a genuine hope that semaglutide wouldn't just help with weight or glucose, but could also act as a shield against Alzheimer's. There were studies suggesting a neuroprotective effect, that it could slow cognitive decline. It was like finding an added bonus in something that was already working. However, as in life itself, reality has just given us a stark wake-up call.

Just a few weeks ago, at the conclusion of the Phase III clinical trials we were all eagerly awaiting, the verdict was clear: semaglutide failed to slow the progression of mild Alzheimer's. It pained me to read the internal report, because I know that many families here, caring for loved ones with this disease, had pinned their hopes on this. The data, which we handle carefully within the industry, showed that while the drug works wonders on metabolism, when it comes to memory loss and cognitive function, there was simply no significant difference between those taking the drug and those receiving a placebo. It's a full stop to one of the most exciting hypotheses put forward in recent years.

What you need to know if you're already using semaglutide

That it doesn't work for Alzheimer's doesn't take away from its effectiveness for what it was approved for. But here's where I want to be straight with you, because in my experience, people tend to skip steps. If you're considering using Wegovy 0.25mg or any other form, keep this in mind:

• It's not for everyone: The initial 0.25mg dose is designed to let your body adjust. Skipping the dosage or starting with a higher one could land you straight in hospital with pancreatitis.
• The delivery system is not optional: That "pre-filled pen with 1.5mL of subcutaneous solution" isn't just packaging. The way it's administered and the Novofine Plus needles are designed to minimise pain and ensure the dose is accurate.
• It's a treatment, not a one-month fad: Semaglutide works while you're using it. I've seen cases of people using it for an event and then stopping, only to regain the weight and then some. This is a long-term commitment, if your doctor deems it necessary.

The "local" factor and the grey market

Here, we have a very particular relationship with medication. We tend to self-prescribe and look for that "just give me a little bit" approach. With semaglutide, this has been chaotic. I've seen WhatsApp groups sharing sellers offering "generic Wegovy" or the "version for diabetics" as if they were sweets. I'm telling you with the confidence of someone who's seen both sides of the coin: don't take the risk. The Novofine Plus needles that come in the official box aren't a luxury; they're part of a safety protocol. Buying this stuff on the black market is playing Russian roulette with your health.

The failure of the studies to slow Alzheimer's isn't bad news per se, but an invitation to get our feet back on the ground. Science moves forward, sometimes with stumbles, but it keeps moving forward. Semaglutide is an incredibly useful tool for those who truly need it under medical supervision. For everyone else, the lesson is clear: don't look for shortcuts, especially when it comes to your brain and your wellbeing. If your doctor prescribed it, trust the process, respect the doses, and that subcutaneous delivery system. If you only want it because it's trendy, maybe this is the time to sit down and think about whether it's worth playing with fire.